Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers

NCT01383096 is registered in ClinicalTrials.gov with Medicines for Malaria Venture as lead sponsor.

NCT NCT01383096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01383096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers
Lead sponsor
Medicines for Malaria Venture
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2012
Completion date
August 31, 2012
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers